Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.17 USD | -1.67% | -2.93% | -30.57% |
Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.